Alder BioPharmaceuticals® to Present at 26th Annual Credit Suisse Healthcare Conference
BOTHELL, Wash., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will webcast its presentation at the 26th Annual …